A share price of Sensei Biotherapeutics Inc [SNSE] is currently trading at $10.56, up 21.38%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The SNSE shares have gain 24.97% over the last week, with a monthly amount glided 21.66%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Stephens started tracking the stock with Overweight rating on May 14, 2024, and set its price target to $5. On July 01, 2021, downgrade downgraded it’s rating to Hold but maintained its price target of $12 on the stock. Oppenheimer downgraded its rating to a Perform and decreased its price target to $14 on June 29, 2021. Piper Sandler initiated its recommendation with an Overweight and recommended $25 as its price target on March 01, 2021. Oppenheimer started tracking with an Outperform rating for this stock on March 01, 2021, and assigned it a price target of $36. In a note dated March 01, 2021, Citigroup initiated a Buy rating and provided a target price of $30 on this stock.
Sensei Biotherapeutics Inc experienced fluctuations in its stock price throughout the past year between $5.00 and $18.35. Currently, Wall Street analysts expect the stock to reach $5.5 within the next 12 months. Sensei Biotherapeutics Inc [NASDAQ: SNSE] shares were valued at $10.56 at the most recent close of the market. An investor can expect a potential drop of -47.92% based on the average SNSE price forecast.
Analyzing the SNSE fundamentals
Gross Profit Margin for this corporation currently stands at 0.38% with Operating Profit Margin at -47.07%, Pretax Profit Margin comes in at -44.37%, and Net Profit Margin reading is -44.37%. To continue investigating profitability, this company’s Return on Assets is posted at -0.87, Equity is -0.8 and Total Capital is -1.11. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 9.29 points at the first support level, and at 8.02 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.25, and for the 2nd resistance point, it is at 11.94.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Sensei Biotherapeutics Inc [NASDAQ:SNSE] is 7.64. As well, the Quick Ratio is 7.64, while the Cash Ratio is 2.38.
Transactions by insiders
Recent insider trading involved Cambrian BioPharma Inc, 10% Owner, that happened on Dec 04 ’25 when 5844.0 shares were purchased. 10% Owner, Cambrian BioPharma Inc completed a deal on Dec 04 ’25 to buy 21222.0 shares.
